메뉴 건너뛰기




Volumn 28, Issue 1, 2014, Pages 41-47

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma

(14)  Merchante, Nicolás a,n   Merino, Esperanza b,o   Rodríguez Arrondo, Francisco c,o   Tural, Cristina d   Muñoz, Josefa e,o   Delgado Fernández, Marcial f,n   Jover, Francisco g,o   Galindo, Maria J h,o   Rivero, Antonio i,n   López Aldeguer, José j,o   Aguirrebengoa, Koldo k,o   Romero Palacios, Alberto l,n   Martínez, Eduardo m,o   Pineda, Juan A a,n  


Author keywords

Cirrhosis; Hepatitis C virus; Hepatocellular carcinoma; HIV; Sustained virological response

Indexed keywords

SORAFENIB;

EID: 84892368920     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000005     Document Type: Article
Times cited : (31)

References (29)
  • 1
    • 61749087148 scopus 로고    scopus 로고
    • Emerging role of hepatocellular among liverrelated causes of deaths in HIV-infected patients: The French National Mortalité 2005 study
    • Salmon-Ceron D, Rosenthal E, Lewden C, Bouteloup V, May T, Burty C, et al. Emerging role of hepatocellular among liverrelated causes of deaths in HIV-infected patients: the French National Mortalité 2005 study. J Hepatol 2009; 50:736-745.
    • (2009) J Hepatol , vol.50 , pp. 736-745
    • Salmon-Ceron, D.1    Rosenthal, E.2    Lewden, C.3    Bouteloup, V.4    May, T.5    Burty, C.6
  • 3
    • 84870700659 scopus 로고    scopus 로고
    • The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States
    • Sahasrabuddhem VV, Shiels MS, McGlynn KA, Engels EA. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2012; 118:6226-6233.
    • (2012) Cancer , vol.118 , pp. 6226-6233
    • Sahasrabuddhem, V.V.1    Shiels, M.S.2    McGlynn, K.A.3    Engels, E.A.4
  • 4
    • 84872144438 scopus 로고    scopus 로고
    • The prevalence of cirrhosis and hepatocellular carcinoma in patients with HIV infection
    • Ioannou GN, Bryson CL, Weiss NS, Miller R, Scott JD, Boyko EJ. The prevalence of cirrhosis and hepatocellular carcinoma in patients with HIV infection. Hepatology 2013; 57:249-257.
    • (2013) Hepatology , vol.57 , pp. 249-257
    • Ioannou, G.N.1    Bryson, C.L.2    Weiss, N.S.3    Miller, R.4    Scott, J.D.5    Boyko, E.J.6
  • 5
    • 33845669536 scopus 로고    scopus 로고
    • A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: A nationwide, multicentre study in Taiwan
    • Yu ML, Lin SM, Chuang WL, Dai CY, Wuang JH, Lu SN, et al. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Antivir Ther 2006; 11:985-994.
    • (2006) Antivir Ther , vol.11 , pp. 985-994
    • Yu, M.L.1    Lin, S.M.2    Chuang, W.L.3    Dai, C.Y.4    Wuang, J.H.5    Lu, S.N.6
  • 6
    • 19944428400 scopus 로고    scopus 로고
    • Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
    • Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, et al. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med 2005; 142:105-114.
    • (2005) Ann Intern Med , vol.142 , pp. 105-114
    • Shiratori, Y.1    Ito, Y.2    Yokosuka, O.3    Imazeki, F.4    Nakata, R.5    Tanaka, N.6
  • 7
    • 77956635697 scopus 로고    scopus 로고
    • Outcome of sustained virological responders with histologically advanced chronic hepatitis C
    • Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, de Santo JL, et al. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 2010; 52:833-844.
    • (2010) Hepatology , vol.52 , pp. 833-844
    • Morgan, T.R.1    Ghany, M.G.2    Kim, H.Y.3    Snow, K.K.4    Shiffman, M.L.5    De Santo, J.L.6
  • 8
    • 0032996855 scopus 로고    scopus 로고
    • Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: A retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group
    • Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, et al. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group. J Hepatol 1999; 30:653-659.
    • (1999) J Hepatol , vol.30 , pp. 653-659
    • Okanoue, T.1    Itoh, Y.2    Minami, M.3    Sakamoto, S.4    Yasui, K.5    Sakamoto, M.6
  • 9
    • 35648970573 scopus 로고    scopus 로고
    • Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alfa and ribavirin
    • Braks RE, Ganne-Carrie N, Fontaine H, Paries J, Grando-Lemaire V, Beaugrand M, et al. Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alfa and ribavirin. World J Gastroenterol 2007; 13: 5648-5653.
    • (2007) World J Gastroenterol , vol.13 , pp. 5648-5653
    • Braks, R.E.1    Ganne-Carrie, N.2    Fontaine, H.3    Paries, J.4    Grando-Lemaire, V.5    Beaugrand, M.6
  • 10
    • 75349096812 scopus 로고    scopus 로고
    • Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
    • Singal AK, Singh A, Jaganmohan S, Guturu P, Mummadi R, Kuo YF, et al. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2010; 8:192-199.
    • (2010) Clin Gastroenterol Hepatol , vol.8 , pp. 192-199
    • Singal, A.K.1    Singh, A.2    Jaganmohan, S.3    Guturu, P.4    Mummadi, R.5    Kuo, Y.F.6
  • 11
    • 33947360829 scopus 로고    scopus 로고
    • Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
    • Bruno S, Stroffolini T, Colombo M, Bolani S, Benvegnù L, Mazzella G, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology 2007; 45:579-587.
    • (2007) Hepatology , vol.45 , pp. 579-587
    • Bruno, S.1    Stroffolini, T.2    Colombo, M.3    Bolani, S.4    Benvegnù, L.5    Mazzella, G.6
  • 12
    • 68949183159 scopus 로고    scopus 로고
    • Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
    • Berenguer J, Alvarez-Pellicer J, Mart?́n PM, López-Aldeguer J, von-Wichmann MA, Quereda C, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50:407-413.
    • (2009) Hepatology , vol.50 , pp. 407-413
    • Berenguer, J.1    Alvarez-Pellicer, J.2    Mart́n, P.M.3    López-Aldeguer, J.4    Von-Wichmann, M.A.5    Quereda, C.6
  • 13
    • 84864129035 scopus 로고    scopus 로고
    • Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV
    • Limketkai BN, Mehta SH, Sutcliffe CG, Higgins YM, Torbenson MS, Brinkley SC, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA 2012; 308:370-378.
    • (2012) JAMA , vol.308 , pp. 370-378
    • Limketkai, B.N.1    Mehta, S.H.2    Sutcliffe, C.G.3    Higgins, Y.M.4    Torbenson, M.S.5    Brinkley, S.C.6
  • 14
    • 28844480321 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
    • (2005) Hepatology , vol.42 , pp. 1208-1236
    • Bruix, J.1    Sherman, M.2
  • 15
    • 79952231921 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma: An update
    • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53:1020-1022.
    • (2011) Hepatology , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 16
    • 34248592912 scopus 로고    scopus 로고
    • Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV international panel
    • Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV international panel. AIDS 2007; 21:1073-1089.
    • (2007) AIDS , vol.21 , pp. 1073-1089
    • Soriano, V.1    Puoti, M.2    Sulkowski, M.3    Cargnel, A.4    Benhamou, Y.5    Peters, M.6
  • 17
    • 77957825574 scopus 로고    scopus 로고
    • Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus
    • Pineda JA, Caruz A, Rivero A, Neukam K, Salas I, Camacho A, et al. Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2010; 51:788-795.
    • (2010) Clin Infect Dis , vol.51 , pp. 788-795
    • Pineda, J.A.1    Caruz, A.2    Rivero, A.3    Neukam, K.4    Salas, I.5    Camacho, A.6
  • 18
    • 0345299824 scopus 로고    scopus 로고
    • Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis
    • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
    • (1996) N Engl J Med , vol.334 , pp. 693-699
    • Mazzaferro, V.1    Regalia, E.2    Doci, R.3    Andreola, S.4    Pulvirenti, A.5    Bozzetti, F.6
  • 19
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: The BCLC staging classification
    • Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19:329-338.
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Bru, C.2    Bruix, J.3
  • 20
    • 84871487025 scopus 로고    scopus 로고
    • Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis
    • Van der Meer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, et al. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308:2584-2593.
    • (2012) JAMA , vol.308 , pp. 2584-2593
    • Van Der Meer, A.J.1    Veldt, B.J.2    Feld, J.J.3    Wedemeyer, H.4    Dufour, J.F.5    Lammert, F.6
  • 21
    • 67349105629 scopus 로고    scopus 로고
    • Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis
    • Raimondi S, Bruno S, Mondelli MU, Maisonneuve P. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. J Hepatol 2009; 50:1142-1154.
    • (2009) J Hepatol , vol.50 , pp. 1142-1154
    • Raimondi, S.1    Bruno, S.2    Mondelli, M.U.3    Maisonneuve, P.4
  • 22
    • 80052825683 scopus 로고    scopus 로고
    • HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
    • Nkontchou G, Ziol M, Aout M, Lhabadie M, Baazia Y, Mahmoudi A, et al. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis. J Viral Hepat 2011; 18:e516-e522.
    • (2011) J Viral Hepat , vol.18
    • Nkontchou, G.1    Ziol, M.2    Aout, M.3    Lhabadie, M.4    Baazia, Y.5    Mahmoudi, A.6
  • 27
    • 84877262187 scopus 로고    scopus 로고
    • Safety and efficacy of telaprevir or boceprevir in combination with peginterferon alfa/ribavirin, in 497 cirrhotic non responders. Week 16 analysis of the French early access program (ANRS CO20-CUPIC) in real-life setting)
    • Boston, MA; 9-12 November 2012
    • Hezode C, Dorival C, Zoulim F, Larrey D, Pol S, Cacoub P, et al. Safety and efficacy of telaprevir or boceprevir in combination with peginterferon alfa/ribavirin, in 497 cirrhotic non responders. Week 16 analysis of the French early access program (ANRS CO20-CUPIC) in real-life setting). 63rd Annual Meeting of the American Association for the Study of Liver Diseases. Boston, MA; 9-12 November 2012.
    • 63rd Annual Meeting of the American Association for the Study of Liver Diseases
    • Hezode, C.1    Dorival, C.2    Zoulim, F.3    Larrey, D.4    Pol, S.5    Cacoub, P.6
  • 28
    • 84892368388 scopus 로고    scopus 로고
    • Rapid virological response in HIV/HCVcoinfected patients with genotype 1 receiving telaprevir or boceprevir outside clinical trials: Results from HEPAVIRTHERAPY cohort
    • 24-28 April 2013; Amsterdam, The Netherlands. Abstract 1860
    • Mira JA, Camacho A, López Cortés LF, Márquez M, Cifuentes C, Rivero-Juárez A, et al. Rapid virological response in HIV/HCVcoinfected patients with genotype 1 receiving telaprevir or boceprevir outside clinical trials: results from HEPAVIRTHERAPY cohort. 48th Annual Meeting of the European Association for the Study of the Liver; 24-28 April 2013; Amsterdam, The Netherlands. Abstract 1860.
    • 48th Annual Meeting of the European Association for the Study of the Liver
    • Mira, J.A.1    Camacho, A.2    López Cortés, L.F.3    Márquez, M.4    Cifuentes, C.5    Rivero-Juárez, A.6
  • 29
    • 0037083159 scopus 로고    scopus 로고
    • Alcohol and hepatocellular carcinoma: The effect of lifetime intake and hepatitis virus infection in men and women
    • Donato F, Tagger A, Gelatti U, Parrinello G, Boffetta P, Albertini A, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infection in men and women. Am J Epidemiol 2002; 155:323-331.
    • (2002) Am J Epidemiol , vol.155 , pp. 323-331
    • Donato, F.1    Tagger, A.2    Gelatti, U.3    Parrinello, G.4    Boffetta, P.5    Albertini, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.